Tanaz R. Ferzandi, MD, MA Director, Division of Urogynecology and Pelvic Reconstructive Surgery Assistant Professor, Department of Obstetrics and Gynecology Tufts Medical Center Boston, MA
AMA PRA Category 1 Credit™ Medium
Mobile + Online on QuantiaMD
Overactive bladder (OAB) is the most common cause of urinary incontinence or loss of bladder control in adults and affects 30% to 60% of older women and 10% to 35% of older men in the United States. The symptoms of OAB often lead to additional medical and psychological problems and can have a detrimental impact on quality of life. Due to a variety of barriers, however, OAB is underdiagnosed and undertreated.
Primary care and OB/GYN clinicians have the opportunity to improve outcomes in patients with OAB by increasing the recognition and accurate diagnosis of OAB. This activity will help to expand clinicians’ knowledge and competency in the diagnosis of OAB and improve outcomes for many patients who suffer from this condition.
This activity is jointly provided by Global Education Group and MCM Education
This educational activity is designed to meet the needs of OB/GYNs, primary care physicians, nurses, nurse practitioners (NPs), and physician assistants (PAs) involved in the diagnosis and treatment of patients with OAB.
Upon completion of this educational activity, the participant should be able to:
Describe effective patient communication strategies to address symptoms of OAB and better identify patients suffering from this disorder
Explain a differential diagnosis in patients with symptoms of OAB using the procedures and measures recommended in guidelines from the American Urological Association.
Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Tanaz R. Ferzandi, MD, MA, discloses that she has served as a consultant for Hologic, Inc.
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Amanda Glazar, PhD: Nothing to disclose
Andrea Funk: Nothing to disclose
Ashley Marostica, RN, MSN: Nothing to disclose
Lillian McVey: Nothing to disclose
Kathleen Hines: Nothing to disclose
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global and MCM Education do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and MCM Education. Global is accredited by the ACCME to provide continuing medical education for physicians.
Global Education Group designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For information about the accreditation of this program, please contact Global at 303-395-1782 or email@example.com. This activity is jointly provided by Global Education Group and MCM Education.
- Complete the pre-activity assessment.
- Review the educational activity.
- Complete the post-activity assessment and score a minimum of 80% (you are allowed two retakes).
- Complete the evaluation.
- View, print, or save a CME certificate verifying your credit/participation in this activity.
- There is no charge for CME credit.
Commercial Support Statements
Supported by an independent educational grant from Astellas Pharma US, Inc.
* Link to and Log into program on QuantiaMD.com
* Complete the pre-activity assessment.
* Review the educational activity
* Complete the post-activity assessment and score a minimum of 75% (you are allowed two retakes).
* Complete the evaluation
* View, print, or save a CME certificate verifying your
credit/participation in this activity Computer Requirements: Minimum System Requirements: • Pentium III, 600 MHz or Equivalent Processor • 512 MB of RAM • Windows XP, Vista, or 7 • Mac OS X • 800x600 Monitor Resolution • 16-bit Color • 16 bit Sound Card with Speakers
There is no charge for CME credit.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.